The fusion of macrophages and breast cancer cells strengthened the activity TCF/LEF transcription factor and promoted the expression of downstream target genes (including cyclin D1 and c-MYC), leading to the promotion of tumor progression, metastasis, and EMT process [65]. This evidence concerns the gene MYC and breast cancer.